vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and B&G Foods, Inc. (BGS). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $439.3M, roughly 1.9× B&G Foods, Inc.). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs -4.4%, a 4.9% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -4.7%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -12.8%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.
ACHC vs BGS — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $439.3M |
| Net Profit | $4.5M | $-19.1M |
| Gross Margin | — | 22.5% |
| Operating Margin | — | 2.5% |
| Net Margin | 0.5% | -4.4% |
| Revenue YoY | 7.5% | -4.7% |
| Net Profit YoY | -50.8% | -356.5% |
| EPS (diluted) | $0.05 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | $439.3M | ||
| Q2 25 | $869.2M | $424.4M | ||
| Q1 25 | $770.5M | $425.4M | ||
| Q4 24 | $774.2M | $551.6M | ||
| Q3 24 | $815.6M | $461.1M | ||
| Q2 24 | $796.0M | $444.6M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | $-19.1M | ||
| Q2 25 | $30.1M | $-9.8M | ||
| Q1 25 | $8.4M | $835.0K | ||
| Q4 24 | $32.6M | $-222.4M | ||
| Q3 24 | $68.1M | $7.5M | ||
| Q2 24 | $78.5M | $3.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 22.5% | ||
| Q2 25 | — | 20.5% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 22.2% | ||
| Q2 24 | — | 20.7% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | 2.5% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | 8.4% | ||
| Q4 24 | 4.9% | -46.6% | ||
| Q3 24 | 12.1% | 11.1% | ||
| Q2 24 | 13.4% | 9.9% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | -4.4% | ||
| Q2 25 | 3.5% | -2.3% | ||
| Q1 25 | 1.1% | 0.2% | ||
| Q4 24 | 4.2% | -40.3% | ||
| Q3 24 | 8.4% | 1.6% | ||
| Q2 24 | 9.9% | 0.9% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | $-0.24 | ||
| Q2 25 | $0.33 | $-0.12 | ||
| Q1 25 | $0.09 | $0.01 | ||
| Q4 24 | $0.36 | $-2.81 | ||
| Q3 24 | $0.74 | $0.09 | ||
| Q2 24 | $0.85 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $60.9M |
| Total DebtLower is stronger | $2.5B | $2.0B |
| Stockholders' EquityBook value | $2.0B | $470.7M |
| Total Assets | $5.5B | $2.9B |
| Debt / EquityLower = less leverage | 1.29× | 4.30× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | $60.9M | ||
| Q2 25 | $131.4M | $54.1M | ||
| Q1 25 | $91.2M | $61.2M | ||
| Q4 24 | $76.3M | $50.6M | ||
| Q3 24 | $82.1M | $54.7M | ||
| Q2 24 | $77.2M | $40.3M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | $2.0B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.2B | $2.0B | ||
| Q4 24 | $2.0B | $2.0B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.0B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | $470.7M | ||
| Q2 25 | $3.1B | $501.4M | ||
| Q1 25 | $3.0B | $513.1M | ||
| Q4 24 | $3.1B | $524.8M | ||
| Q3 24 | $3.0B | $755.3M | ||
| Q2 24 | $3.0B | $765.0M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | $2.9B | ||
| Q2 25 | $6.3B | $2.9B | ||
| Q1 25 | $6.1B | $3.0B | ||
| Q4 24 | $6.0B | $3.0B | ||
| Q3 24 | $5.9B | $3.4B | ||
| Q2 24 | $5.7B | $3.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | 4.30× | ||
| Q2 25 | 0.74× | 3.97× | ||
| Q1 25 | 0.72× | 3.91× | ||
| Q4 24 | 0.64× | 3.85× | ||
| Q3 24 | 0.62× | 2.75× | ||
| Q2 24 | 0.62× | 2.67× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $-64.6M |
| Free Cash FlowOCF − Capex | — | $-70.7M |
| FCF MarginFCF / Revenue | — | -16.1% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $54.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | $-64.6M | ||
| Q2 25 | $133.5M | $17.8M | ||
| Q1 25 | $11.5M | $52.7M | ||
| Q4 24 | $116.7M | $80.3M | ||
| Q3 24 | $163.1M | $4.2M | ||
| Q2 24 | $171.1M | $11.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | $-70.7M | ||
| Q2 25 | $-34.2M | $11.5M | ||
| Q1 25 | $-163.2M | $42.4M | ||
| Q4 24 | $-86.8M | $71.7M | ||
| Q3 24 | $-27.1M | $-679.0K | ||
| Q2 24 | $16.9M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | -16.1% | ||
| Q2 25 | -3.9% | 2.7% | ||
| Q1 25 | -21.2% | 10.0% | ||
| Q4 24 | -11.2% | 13.0% | ||
| Q3 24 | -3.3% | -0.1% | ||
| Q2 24 | 2.1% | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | 1.4% | ||
| Q2 25 | 19.3% | 1.5% | ||
| Q1 25 | 22.7% | 2.4% | ||
| Q4 24 | 26.3% | 1.6% | ||
| Q3 24 | 23.3% | 1.0% | ||
| Q2 24 | 19.4% | 1.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | 63.17× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 0.56× | ||
| Q2 24 | 2.18× | 2.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
BGS
| Specialty Segment | $150.5M | 34% |
| Meals Segment | $110.0M | 25% |
| Spices And Flavor Solutions Segment | $101.4M | 23% |
| Frozen And Vegetables Segment | $77.4M | 18% |
